Amplia Therapeutics (ASX:ATX) Pre-Tax Income : A$-4.50 Mil (TTM As of Sep. 2023)

Amplia Therapeutics Pre-Tax Income Chart

Amplia Therapeutics Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Pre-Tax Income		Get a 7-Day Free Trial					-2.22	-2.28	-3.64	-6.24	-4.50

Amplia Therapeutics Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-2.32	-2.91	-3.33	-1.13	-3.37

Competitive Comparison of Amplia Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Amplia Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplia Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Pre-Tax Income falls into.

Amplia Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Amplia Therapeutics's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Amplia Therapeutics's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-4.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplia Therapeutics  (ASX:ATX) Pre-Tax Income Explanation

Amplia Therapeutics's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

During the past 11 years, Amplia Therapeutics's highest Pretax Margin was -17456.67%. The lowest was -17456.67%. And the median was -17456.67%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplia Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (ASX:ATX) Business Description